|
|
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study (PR Newswire via Yahoo! Finance)
Isolagen, Inc. announced today the completion of enrollment of approximately 120 patients in its Phase II/III Study IT-A-008 investigating the Isolagen Therapy for the treatment of moderate to severe acne scars.
QLT to divest acne treatment following FDA ruling (MSN Money Canada)
TORONTO (Reuters) - QLT Inc (QLT.TO) said on Monday that the U.S. Food and Drug Administration removed key blood monitoring requirements for its topical acne medicine Aczone, clearing a path for the company to divest the treatment.
Miami Plastic Surgeon Offers Hope to Acne Scarred Patients (PR Newswire via Yahoo! Finance)
Dr. Julio Gallo, a Miami facial plastic surgeon is giving hope to patients suffering from disfiguring acne scarring with new laser technology.
QLT Gets Screening Requirement Lifted (AP via Yahoo! Finance)
Biotechnology company QLT Inc. said Monday the Food and Drug Administration removed a blood screening and monitoring requirement for its acne treatment, Aczone.
QLT jumps as regulators clear way for sale of U.S. unit (The Globe and Mail)
Stock in struggling Vancouver pharmaceutical company QLT Inc. surged Monday morning after U.S. regulators removed a blood testing requirement from its Aczone acne treatment.
More News (Daily Breeze)
Sorry, no items are currently available. Acne isn't a problem that magically disappears when you turn 20. Even though it's thought of as a teen skin problem, many adults - in fact, most adults - suffer from at least occasional outbreaks of acne.
QLT jumps as regulators clear way for sale of U.S. unit (The Globe and Mail)
U.S. regulators removed a blood testing requirement from its Aczone acne treatment, a treatment owned by U.S. division QLT wants to sell off
Isolagen, Inc. Completes Enrollment In Isolagen Therapy(TM) Phase II/III Acne Scar Study (Medical News Today)
Isolagen(TM), Inc. (Amex: ILE) announced the completion of enrollment of approximately 120 patients in its Phase II/III Study IT-A-008 investigating the Isolagen Therapy(TM) for the treatment of moderate to severe acne scars. Treatments, which will be administered at seven clinical sites across the U.S., have now commenced.
|
Back to Information on Acne
Back to Acne News Arc |
|
|
